Search Share Prices
GSK Shares - GSK sees positive COPD trial results
Proactive Investors - GSK PLC (LON: GSK) announced positive results from a Phase III clinical trial, MATINEE, evaluating Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD).
A history of... GlaxoSmithKline
Assistant Editor, Hannah Blake, picks this series back up, starting here with the history of GlaxoSmithKline. GlaxoSmithKline (GSK) is a science-led global healthcare company, which headquarters ...
With 86% institutional ownership, GSK plc (LON:GSK) is a favorite amongst the big guns
Key Insights Given the large stake in the stock by institutions, GSK's stock price might be vulnerable to their ...
GSK shares higher after Delaware Zantac ruling
GSK PLC (LON: GSK) shares opened higher after Delaware's Supreme Court said it will hear an appeal by the UK drug market and other pharmaceutical companies, ...
GSK Shares Rise as Court Decision on Zantac Evidence Reviewed
GSK Plc shares rose on Wednesday, buoyed by a US court’s decision to review whether evidence supporting claims that heartburn drug Zantac causes cancer is scientifically sound.